evaluation
safety
amantadine
hc
role
respiratory
viral
infection
child
cystic
fibrosis
amantadine
hc
antiviral
drug
clinically
effective
strain
influenza
virus
evaluated
double
blind
trial
child
cystic
fibrosis
initial
appearance
influenza
england
virus
new
england
area
infection
variant
strain
influenza
virus
reach
epidemic
proportion
study
effectiveness
amantadine
study
population
could
fully
assessed
however
potential
symptomatic
biochemical
toxicity
amantadine
carefully
monitored
pediatric
population
serologic
screening
complement
fixation
test
indicated
respiratory
virus
may
important
pathogen
exacerbation
respiratory
disease
patient
cystic
fibrosis
